Michelle Ho
VP Strategy and Operations at Renasant Bio
Michelle Ho
VP Strategy and Operations at Renasant Bio
San Francisco Bay Area
Overview
Work Experience
VP Strategy and Operations
2024 - Current
Operating Principal
2023 - 2024
Senior Associate
2022 - 2022
Associate
2020 - 2021
Analyst
2018 - 2019
Board Observer
2021 - 2024
Board Observer
2021 - 2024
Board Observer
2018 - 2024
Board Observer
2020 - 2024
Board Observer
2019 - 2023
Board Observer
2022 - 2022
Acquired by Bionano Genomics in November 2022
Entrepreneurship Fellow
2016 - 2018
• Managed 2 portfolio life science startups in therapeutics (rHDL therapeutics) and medical devices (GuidaBot) • Developed pitch decks and led business development efforts, including key collaboration with leading siRNA biotech company • Performed market analysis, product-market-fit, and business model development for portfolio technologies • Initiated 2 new collaborations with NASH and rare metabolic disease experts • Awarded $325k NIH SBIR Phase I grant for development and safety/toxicity assessment of novel lipid-based nanoparticles for therapeutic siRNA delivery • Created and led monthly entrepreneurship book club • Led branding and outreach efforts for Fannin Innovation Studio
Director of Operations
2016 - 2018
• Led business development, validated value propositions via customer interviews with key opinion leaders in functional neurosurgery and shadowing laser ablation procedures • Directed prototype development of robotic MRI-compatible neurosurgical guidance device • Determined regulatory and go-to-market strategy • Awarded $225k NSF STTR Phase I grant to develop proof-of-concept 4-DoF robotic prototype • Won 1st Place Elevator Pitch at Texas A&M New Ventures Competition 2017 • Won acceptance into TMCx Medical Device Accelerator - Class 5 Cohort